| PDF (712kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-330420
- DOI to cite this document:
- 10.5283/epub.33042
Abstract
Background Adenocarcinoma of the pancreas is one of the most aggressive cancer diseases affecting the human body. The oncogenic potential of this type of cancer is mainly characterized by its extreme growth rate triggered by the activation of signaling cascades. Modern oncological treatment strategies aim at efficiently modulating specific signaling and transcriptional pathways. Recently, ...
Owner only: item control page